Home > Insider Trading > Filing (0001209191-20-027672)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1242825	M Jeffrey Leiden	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-05-05	24,216	$187.53	76,707	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	35,502	$96.87	112,209	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	4,470	$91.05	116,679	No	4	M	Direct
Common Stock	Acquisiton	2020-05-05	24,349	$155.57	141,028	No	4	M	Direct
Common Stock	Disposition	2020-05-05	4,220	$265.57	136,808	No	4	S	Direct
Common Stock	Disposition	2020-05-05	4,921	$266.66	131,887	No	4	S	Direct
Common Stock	Disposition	2020-05-05	10,878	$267.62	121,009	No	4	S	Direct
Common Stock	Disposition	2020-05-05	22,613	$268.86	98,396	No	4	S	Direct
Common Stock	Disposition	2020-05-05	15,681	$269.56	82,715	No	4	S	Direct
Common Stock	Disposition	2020-05-05	6,003	$270.86	76,712	No	4	S	Direct
Common Stock	Disposition	2020-05-05	11,832	$272.12	64,880	No	4	S	Direct
Common Stock	Disposition	2020-05-05	12,849	$272.97	52,031	No	4	S	Direct
Common Stock	Disposition	2020-05-05	5,375	$273.70	46,656	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-05	24,216	$0.00	24,216	$187.53
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-05	35,502	$0.00	35,502	$96.87
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-05	4,470	$0.00	4,470	$91.05
Common Stock	Stock Option (Right to Buy)	Disposition	2020-05-05	24,349	$0.00	24,349	$155.57

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
48,431	2029-02-25	No	4	M	Direct
70,998	2024-07-14	No	4	M	Direct
102,806	2026-02-01	No	4	M	Direct
48,697	2028-02-05	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	440	Indirect	401(k)

Footnotes

Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $265.57 (range $265.16 to $266.10).
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $266.66 (range $266.16 to $267.14).
Open market sales reported on this line occurred at a weighted average price of $267.62 (range $267.16 to $268.14).
Open market sales reported on this line occurred at a weighted average price of $268.86 (range $268.23 to $269.22).
Open market sales reported on this line occurred at a weighted average price of $269.56 (range $269.24 to $270.09).
Open market sales reported on this line occurred at a weighted average price of $270.86 (range $270.26 to $271.23).
Open market sales reported on this line occurred at a weighted average price of $272.12 (range $271.42 to $272.41).
Open market sales reported on this line occurred at a weighted average price of $272.97 (range $272.42 to $273.41).
Open market sales reported on this line occurred at a weighted average price of $273.70 (range $273.42 to $274.06).
Fully vested.